De Angelis D - Search Results

1

Analysing HCV incidence trends in people who inject drugs using serial behavioural and seroprevalence data: A modelling study.

Egan C, Harris RJ, Mitchell HD, Desai M, Mandal S, De Angelis D. Egan C, et al. Among authors: de angelis d. Int J Drug Policy. 2024 Jun 15:104469. doi: 10.1016/j.drugpo.2024.104469. Online ahead of print. Int J Drug Policy. 2024. PMID: 38880700 Free article.

2

Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.

Harris RJ, Ramsay M, Hope VD, Brant L, Hickman M, Foster GR, De Angelis D. Harris RJ, et al. Among authors: de angelis d. Eur J Public Health. 2012 Apr;22(2):187-92. doi: 10.1093/eurpub/ckr083. Epub 2011 Jun 26. Eur J Public Health. 2012. PMID: 21708792

3

Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services.

Harris RJ, Hope VD, Morongiu A, Hickman M, Ncube F, DE Angelis D. Harris RJ, et al. Among authors: de angelis d. Epidemiol Infect. 2012 Jun;140(6):1054-63. doi: 10.1017/S0950268811001634. Epub 2011 Aug 30. Epidemiol Infect. 2012. PMID: 21875456

4

Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.

Hickman M, De Angelis D, Jones H, Harris R, Welton N, Ades AE. Hickman M, et al. Among authors: de angelis d. Addiction. 2013 Sep;108(9):1529-31. doi: 10.1111/add.12185. Epub 2013 Apr 22. Addiction. 2013. PMID: 23600694

5

Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.

Jones HE, Hickman M, Welton NJ, De Angelis D, Harris RJ, Ades AE. Jones HE, et al. Among authors: de angelis d. Am J Epidemiol. 2014 Jun 1;179(11):1383-93. doi: 10.1093/aje/kwu056. Epub 2014 Apr 11. Am J Epidemiol. 2014. PMID: 24727806 Free PMC article.

6

Two decades of successes and failures in controlling the transmission of HIV through injecting drug use in England and Wales, 1990 to 2011.

Hope VD, Harris RJ, De Angelis D, Croxford S, Marongiu A, Parry JV, Ncube F. Hope VD, et al. Among authors: de angelis d. Euro Surveill. 2014 Apr 10;19(14):20762. doi: 10.2807/1560-7917.es2014.19.14.20762. Euro Surveill. 2014. PMID: 24739984 Free article.

7

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England.

Harris RJ, Martin NK, Rand E, Mandal S, Mutimer D, Vickerman P, Ramsay ME, De Angelis D, Hickman M, Harris HE. Harris RJ, et al. Among authors: de angelis d. J Viral Hepat. 2016 Aug;23(8):631-43. doi: 10.1111/jvh.12529. Epub 2016 Mar 29. J Viral Hepat. 2016. PMID: 27025238 Free PMC article.

8

Heterogeneity in Risk and Implications for Hepatitis C Reinfection in People Who Inject Drugs in England.

Hilton B, De Angelis D, Mitchell H, Harris R. Hilton B, et al. Among authors: de angelis d. J Viral Hepat. 2025 Feb;32(2):e14052. doi: 10.1111/jvh.14052. J Viral Hepat. 2025. PMID: 39815998 Free PMC article.

9

Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths.

De Angelis D, Hickman M, Yang S. De Angelis D, et al. Am J Epidemiol. 2004 Nov 15;160(10):994-1004. doi: 10.1093/aje/kwh306. Am J Epidemiol. 2004. PMID: 15522856

10

Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit.

Sweeting MJ, De Angelis D, Hickman M, Ades AE. Sweeting MJ, et al. Among authors: de angelis d. Biostatistics. 2008 Oct;9(4):715-34. doi: 10.1093/biostatistics/kxn004. Epub 2008 Mar 18. Biostatistics. 2008. PMID: 18349037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters